Skip to main content

Table 3 Correlation between BSV of CD133 mRNA with clinicopathological features and Ki-67 LI [n(%)] (n = 31 cases)

From: Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma

Parameter Grouping n(%) Mean ± SD Test value P value
Gender male 24(77.4%) 0.3674 ± 0.1292 Z = -0.520 0.603
  female 7(22.6%) 0.4156 ± 0.1829   
Age(year) 60 10(32.3%) 0.3150 ± 0.1140 Z = -1.648 0.099
  > 60 21(67.7%) 0.4084 ± 0.1452   
Tumor diameter (cm) 5 18(58.1%) 0.3343 ± 0.1212 Z = -2.042 0.041
  > 5 13(41.9%) 0.4393 ± 0.1484   
Histological grade 1 3(9.7%) 0.2555 ± 0.0095 H = 3.501 0.321
  2 13(41.9%) 0.3674 ± 0.1185   
  3 15(48.4) 0.4177 ± 0.1634   
Invasion depth T 1 1(3.2%) 0.2630 ± 0.0311 H = 3.142 0.370
  T 2 5(16.1%) 0.3199 ± 0.1855   
  T 3 13(41.9%) 0.4234 ± 0.1511   
  T 4 12(38.7%) 0.3634 ± 0.1073   
Lymph node metastasis N 0 8(25.8%) 0.2395 ± 0.0309* H = 13.583 0.004
  N 1 12(38.7%) 0.4418 ± 0.1617   
  N 2 7(22.6%) 0.4258 ± 0.1052   
  N 3 4(12.9%) 0.3824 ± 0.0782   
TNM stage II 5(16.1%) 0.3179 ± 0.1862 H = 6.409 0.093
  II 2(6.5%) 0.2257 ± 0.0226   
  III 16(51.6%) 0.3951 ± 0.1461   
  IV 8(25.8%) 0.4207 ± 0.0882   
Lymphatic vessel infiltration positive 18(58.1%) 0.5013 ± 0.1412 Z = -2.142 0.040
  negative 13(41.9%) 0.3343 ± 0.1212   
Vascular infiltration positive 17(54.8%) 0.4783 ± 0.1081 Z = -2.042 0.039
  negative 14(45.2%) 0.3343 ± 0.1212   
Ki-67 LI Lower 16(51.6%) 0.4364 ± 0.1398 Z = -2.332 0.02
  higher 15(48.4%) 0.3164 ± 0.1174   
  1. *: N0 vs N1-3; N1-3 = N1+N2+N3 = 0.4266 ± 0.1320